STOCK TITAN

Dominari Holdings Inc. 8-K Filings

DOMH NASDAQ

Every 8-K that Dominari Holdings Inc. (DOMH) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow DOMH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DOMH filings page.

Rhea-AI Summary

Dominari Holdings Inc. (DOMH) announced that its board of directors authorized a share repurchase program under which the company may buy back up to $5,000,000 of its outstanding common stock. The authorization was approved on September 16, 2026.

Repurchases may occur from time to time through open-market transactions or other permitted methods, including trades conducted under plans adopted in accordance with Rule 10b5-1 and Rule 10b-18 under the Exchange Act. The company can terminate the program at its discretion at any time. Management stated that the decision reflects a focus on shareholder value and capital allocation that supports its growth strategies across wealth management, investment banking, sales and trading, and asset management.

Rhea-AI Summary

Dominari Holdings Inc. entered into Inducement Agreements with holders of its Series A warrants to reduce market overhang. These warrants cover up to 3,124,690 shares of common stock and originally had an exercise price of $3.72 per share.

Holders may either exercise all of their existing warrants for cash at a reduced exercise price of $2.20 per share on or before 4 p.m. ET on September 11, 2026 (Option A), or exchange all of their unexercised warrants for common stock at a 5:1 exchange ratio with no additional consideration (Option B). The company expects to receive approximately $2.9 million of gross proceeds under Option A and to issue approximately 115,000 shares of common stock under Option B. After these actions, it expects approximately 1.2 million Series A warrants will remain unexercised.

Rhea-AI Summary

Dominari Holdings Inc. changed its independent auditor, dismissing CBIZ CPAs P.C. on June 24, 2026 with audit committee approval and appointing Grassi & Co., CPAs, P.C. for the fiscal year ending December 31, 2026.

CBIZ CPAs’ report on the company’s financial statements during its tenure did not include adverse or disclaimed opinions and was not qualified or modified for uncertainty, scope, or accounting principles, and there were no disagreements on accounting, disclosure, or audit procedures as defined by SEC rules. However, the company reports existing material weaknesses in internal control over financial reporting, including limited personnel for timely and accurate closing, insufficient review of fair value transactions, lack of segregation of duties, information technology access control deficiencies, and insufficient documentation of control design and implementation.

Rhea-AI Summary

Dominari Holdings Inc. entered into Inducement Agreements with holders of its Series B warrants to adjust terms and encourage early exercise or exchange. The warrants originally allowed purchase of up to 3,133,880 shares of common stock at an exercise price of $4.22 per share.

Holders could either exercise their existing warrants for cash at a reduced price of $2.50 per share (Option A) or exchange all unexercised warrants for common stock at a 10:3 ratio without additional cash (Option B). The company expects to receive approximately $3.67 million of gross proceeds from Option A elections and to issue about 150,000 shares under Option B, with roughly 1.2 million Series B warrants remaining unexercised. The Option B exchange shares were issued under a Section 3(a)(9) exemption from registration.

Rhea-AI Summary

Dominari Holdings Inc. reported preliminary 2025 results showing rapid growth but continued GAAP losses. Total revenue rose to $123.1 million for the year ended December 31, 2025, up from $21.0 million in 2024, driven mainly by underwriting services of $79.0 million, carried interest of $22.7 million and higher commissions of $19.6 million.

Despite the revenue surge, the company posted a GAAP net loss attributable to common stockholders of $22.4 million, versus a $14.7 million loss in 2024, as compensation, advisory and other costs increased. However, after adding back $55.0 million of non-cash stock-based compensation, adjusted net income was $32.6 million, and adjusted loss from operations narrowed sharply.

The balance sheet strengthened, with cash and cash equivalents rising to $34.0 million and total assets to $112.9 million, while stockholders’ equity increased to $69.4 million. Net cash provided by operating activities improved to $22.7 million, and the company paid $11.9 million of dividends and raised equity capital through common stock issuances and warrant exercises.

Rhea-AI Summary

Dominari Holdings Inc. amended the employment agreements of its Chief Executive Officer, Anthony Hayes, and its President, Kyle Wool, effective March 20, 2026. Each executive will receive a one-time issuance of 3,000,000 shares of common stock from the company.

In exchange, the executives agreed to replace their prior annual bonus provisions with a new performance-based quarterly bonus structure, as detailed in the amendments. These share issuances were approved by shareholder vote on March 4, 2026. All other terms of the original employment agreements remain unchanged.

Rhea-AI Summary

Dominari Holdings Inc. stockholders approved significant changes to the company’s 2022 Equity Incentive Plan at a special meeting held on March 4, 2026. A quorum of 7,019,711 voting shares, representing approximately 43.27% of eligible voting stock as of January 22, 2026, was present in person or by proxy.

Investors approved increasing the number of shares of common stock reserved for issuance under the 2022 Plan by 10,000,000 shares, raising the pool from 11,720,750 to 21,720,750 shares. They also approved an automatic annual increase feature stating that from January 1, 2027 through January 1, 2032, the share reserve will increase each January 1 by the lesser of 20% of total common shares outstanding on the prior December 31 or a smaller amount set by the board. Proposal 1 passed with 6,380,149 votes for, 631,857 against, and 7,705 abstaining. A related adjournment proposal also passed.

Rhea-AI Summary

Dominari Holdings Inc. held its annual meeting on December 10, 2025, where stockholders established a quorum and voted on five proposals.

They elected Class II director Anthony Hayes to a term ending at the 2028 annual meeting and ratified CBIZ CPAs P.C. as independent auditor for the year ending December 31, 2025. Stockholders approved an amendment to the 2022 Equity Incentive Plan, increasing the shares reserved for awards from 11,404,404 to 11,720,750 common shares. They also approved, for Nasdaq Listing Rule 5635(d) purposes, the potential issuance of more than 19.99% of outstanding common stock or voting power in certain non‑public financing transactions under Advisory Agreements, at prices that may be below the Nasdaq “Minimum Price.” Finally, stockholders approved renewing the company’s Rights Agreement and extending rights under it through October 11, 2026.

Rhea-AI Summary

Dominari Holdings Inc. plans to hold its 2025 Annual Meeting of Stockholders on December 10, 2025. Stockholders of record at the close of business on October 13, 2025 will be entitled to vote at the meeting. The specific time and location will be provided in the company’s definitive proxy statement to be filed.

Because this meeting date is more than 30 days after the anniversary of the 2024 annual meeting, Dominari set a new deadline for stockholder proposals. Proposals submitted under Rule 14a‑8, as well as any director nominations or other proposals to be presented at the meeting but not included in the proxy materials, must be received by October 18, 2025. All submissions must be sent to the Corporate Secretary at the company’s New York address.

Rhea-AI Summary

Dominari Holdings Inc. filed an 8-K reporting a material event: an Employment Agreement dated September 21, 2025 between the company and Tim Ledwick. The filing reference lists the agreement as Exhibit 10.1 and indicates the cover page interactive XBRL file is embedded. The document is a short submission showing the existence and execution date of the agreement but contains no financial terms, compensation figures, indicia of change in control provisions, or disclosure of material business impact within the excerpt provided. Investors therefore know a named executive employment contract was executed but must await the full exhibit for material terms and potential effects on governance or expenses.

Rhea-AI Summary

Dominari Holdings Inc. reported that its Board of Directors appointed Brian Parsley as a Class III director, effective September 5, 2025, filling the vacancy created by the resignation of Ron Lieberman. Parsley also joined the company’s audit and compensation committees.

The company states there are no arrangements or understandings with other persons related to his appointment, no related-party transactions requiring disclosure, and no new material compensatory plans for him. Parsley brings more than 30 years of experience in entrepreneurship, sales, and leadership development, having founded and successfully exited multiple companies and advised organizations, including large corporations, on performance and culture.

Rhea-AI Summary

Dominari Holdings (Nasdaq:DOMH) filed an 8-K reporting two material governance and compensation actions dated June 24–27, 2025.

Executive compensation: Amendments to CEO Anthony Hayes and President Kyle Wool employment agreements eliminate future stock grants tied to net-revenue milestones in favor of an additional cash bonus. All other terms remain unchanged.

Board change: Director Soo Yu resigned effective June 27, 2025 for non-dispute reasons and continues as Special Projects Manager. The Board size shrinks from seven to six.

  • No financial statements were included.
  • Amendments are filed as Exhibits 10.1 & 10.2.

Investors should weigh lower dilution against higher cash outflows and any governance impact from the board reduction.